The 2026 Nobel Prize in Physiology or Medicine went to Karl Deisseroth, Georg Nagel and Peter Hegemann, "for their discoveries concerning light-gated ion channels and optogenetics".
Optogenetics lets researchers switch specific neurons on and off with light, at millisecond precision. It is now standard equipment in neuroscience labs worldwide.
The protein that made it possible was found in pond scum.
The Problem It Solved
For most of neuroscience's history, there were two ways to interfere with a brain and find out what a region does, and both were blunt.
Electrodes deliver current, which stimulates whatever happens to be nearby — the cells you care about and every other cell sharing that space, which in the brain means several different types doing different jobs.
Drugs are more selective about cell type but hopeless about timing. They diffuse, act over seconds to minutes, and wash out slowly. A neuron fires in about a millisecond.
So the field could lesion a region and see what broke, or stimulate it and see what happened, but could not ask the sharper question: what does this one class of cell, in this one place, actually do — and what happens if it fires right now?
The Answer Was Swimming Toward a Light
Single-celled green algae move toward light to photosynthesise. To do that they need to detect light and convert that detection into movement — which means converting a photon into an electrical signal.
Hegemann's work identified how. The alga Chlamydomonas reinhardtii carries proteins now called channelrhodopsins, which sit in the cell membrane and act as light-operated gates.
In 2003, Nagel, Hegemann and colleagues published the result that made everything else possible. Working with channelrhodopsin-2 (ChR2) — expressed in frog oocytes and mammalian cells rather than in algae — they demonstrated it is "a directly light-switched cation-selective ion channel" which "opens rapidly after absorption of a photon to generate a large permeability for monovalent and divalent cations".
Read that carefully, because the whole field is in it. One protein. Light goes in, ions flow. No intermediate machinery, no cascade of messengers — a channel that is simply open when illuminated and shut when not.
Putting an Algal Protein Into a Brain Cell
A neuron fires when ions cross its membrane and shift its voltage past a threshold. ChR2 moves ions across a membrane when lit.
The two facts fit together, and in 2005 Edward Boyden, Feng Zhang, Ernst Bamberg, Georg Nagel and Karl Deisseroth published the demonstration. They "adapted for this purpose the naturally occurring algal protein Channelrhodopsin-2, a rapidly gated light-sensitive cation channel, by using lentiviral gene delivery in combination with high-speed optical switching to photostimulate mammalian neurons."
What they achieved was "reliable, millisecond-timescale control of neuronal spiking, as well as control of excitatory and inhibitory synaptic transmission."
That is the moment the technique exists. Deliver the gene to neurons, shine light, and those neurons fire — on the timescale that neurons actually operate on.
The name follows directly: opto for the light that provides the timing, genetic for the gene delivery that provides the targeting.
And Then an Off Switch
Turning neurons on is half an experiment. Showing a cell type is necessary for a behaviour requires switching it off.
That arrived in 2007, when Zhang, Deisseroth and colleagues identified "an archaeal light-driven chloride pump (NpHR) from Natronomonas pharaonis for temporally precise optical inhibition of neural activity." Pumping chloride into a neuron pushes its voltage away from firing threshold.
The design detail that made it genuinely useful is the pairing. The authors noted NpHR "is compatible with ChR2 … in that the two opposing probes operate at similar light powers but with well-separated action spectra."
Different colours, opposite effects. One wavelength excites a population, another silences it, in the same animal, during the same experiment.
The Optogenetic Toolkit
Two proteins, borrowed from a green alga and a salt-lake archaeon.
| Tool | Origin | What light does to the neuron |
|---|---|---|
| ToolChR2 (channelrhodopsin-2) | OriginChlamydomonas reinhardtii, a green alga | What light does to the neuronCations flow in — the neuron fires |
| ToolNpHR (halorhodopsin) | OriginNatronomonas pharaonis, an archaeon | What light does to the neuronChloride pumped in — firing is blocked |
Separated by colour, not by chemistry
Because the two respond to well-separated wavelengths, the same animal can carry both and be switched either way during one experiment.
Why It Changed What Questions Could Be Asked
Precision is the whole point, and it has three dimensions at once.
Which cells. The gene can be delivered under control of a promoter active only in one cell type, so only those cells become light-sensitive. Everything else in the tissue ignores the light entirely.
Where. An optical fibre illuminates a defined region, so the manipulation is anatomically specific.
When. Millisecond timing means activity can be driven in patterns that resemble real neural firing, rather than a sustained unnatural blast.
Together those make a genuine causal test possible. Rather than "this region is active when the animal does X", a researcher can ask "if I make exactly these cells fire, right now, does the animal do X?" — and get an answer.
That is the difference between correlation and cause, and it is why the technique spread through neuroscience so quickly. It has since been applied to circuits underlying movement, reward, feeding, fear, sleep and memory.
How the Gene Actually Gets In
The "genetic" half does more work than it gets credit for, and it is where the cell-type precision actually comes from.
A neuron will not make channelrhodopsin unless it is given the instructions. Those instructions are delivered by a viral vector — a virus stripped of its ability to cause disease and loaded with the gene instead. The 2005 demonstration used lentiviral gene delivery; the field has since leaned heavily on adeno-associated viruses, which are better tolerated and come in variants that favour different tissues.
Delivery alone would put the protein in everything the virus reaches, which is not precise enough. The targeting comes from what sits in front of the gene: a promoter, a stretch of DNA that only switches on in particular cell types. Pair the channelrhodopsin gene with a promoter active only in, say, inhibitory interneurons, and only those cells build the protein. Shine light on the whole region and everything else carries on as though nothing happened.
In mouse work this is usually taken further, using lines engineered so that a specific cell population carries the machinery to activate the delivered gene. The result is a technique whose selectivity is genetic rather than anatomical — which is precisely why it could answer questions electrodes never could.
The Three-Name Problem
The 2026 award is also a clean illustration of a rule discussed in our roundup of the 2026 prizes: no more than three people can share a Nobel.
The 2005 Nature Neuroscience paper that demonstrated millisecond control of mammalian neurons lists five authors — Edward Boyden, Feng Zhang, Ernst Bamberg, Georg Nagel and Karl Deisseroth. The prize went to Deisseroth, Nagel and Hegemann. Two authors of the founding demonstration are not among the laureates, and Hegemann, whose work on the algal photoreceptors underpins everything, was not on that paper at all.
This is not a scandal; it is arithmetic. The cap was written when a major advance plausibly came from one or two people in a laboratory. Optogenetics was built over years by overlapping groups across several countries, and any three names will leave out someone whose contribution was load-bearing.
It is worth keeping in mind whenever a prize list is read as a complete account of who did the work. It never is, and increasingly it cannot be.
What Optogenetics Cannot Do
The honest limits matter, particularly because the technique is often described as if it were ready for the clinic.
It requires genetic modification. The target neurons must be made to produce a protein they do not naturally have, usually by viral delivery. In laboratory animals this is routine. In humans it is a far larger proposition.
Light does not travel well through tissue. Blue light is absorbed and scattered within roughly a millimetre of brain tissue, which is why deep-brain work generally requires an implanted optical fibre. Red-shifted variants penetrate better, but the constraint is physical and has not gone away.
The proteins are imperfect. The original ChR2 "desensitizes in continuous light to a smaller steady-state conductance", as its own discovery paper states — meaning sustained illumination does not produce sustained, unchanging current. Much subsequent engineering has gone into variants with better kinetics.
Driving a circuit is not the same as understanding it. Making a population fire in a pattern an experimenter chose demonstrates sufficiency for a behaviour. It does not establish that the brain normally produces that behaviour that way.
Human clinical use so far is narrow and specialised — the most discussed application is restoring a degree of light sensitivity in retinal disease, where the target cells are directly accessible to light without surgery into deep tissue.
The Bottom Line
Optogenetics works because a green alga solved a problem neuroscience needed solved: converting light directly into an ionic current, in a single protein, within milliseconds.
Hegemann and Nagel characterised that protein. Nagel and colleagues showed in 2003 that it functions as a light-switched channel in animal cells. Deisseroth's group, with Boyden and others, showed in 2005 that it could drive mammalian neurons with millisecond precision — and in 2007 added the off switch.
The reason it won a Nobel is not that it answered one big question, but that it changed the kind of question neuroscience could ask at all.
It is also a clean example of something researchers keep pointing out: the work that mattered most was not aimed where it landed. Nobody characterising algal photoreceptors was trying to build a tool for brain science.
For the other five prizes see our guide to the 2026 Nobel Prizes, the physics award in how IceCube detects neutrinos, and more on the light itself in what is a photon. More research explainers in our medicine research hub.
Frequently Asked Questions
What is optogenetics in simple terms?
A method for switching specific neurons on or off using light. Researchers insert the gene for a light-sensitive protein into chosen cells, so only those cells respond. Shining light then opens a channel in the cell membrane, ions flow, and the neuron fires — or, with a different protein and a different colour, is silenced. The gene decides which cells; the light decides when.
Where did the light-sensitive protein come from?
From Chlamydomonas reinhardtii, a single-celled green alga that steers toward light to photosynthesise. It uses proteins called channelrhodopsins to turn light into an electrical signal. Channelrhodopsin-2 was shown in 2003 to work as a directly light-switched, cation-selective ion channel when expressed in animal cells — which is what made the whole technique possible.
How fast is optogenetic control?
Milliseconds. The 2005 paper that established the technique reported "reliable, millisecond-timescale control of neuronal spiking", which matters because that is the timescale neurons actually work on. Drugs act over seconds to minutes, which is far too slow to mimic natural firing patterns.
Can you switch neurons off as well as on?
Yes. In 2007 researchers identified NpHR, a light-driven chloride pump from the archaeon Natronomonas pharaonis, which inhibits firing when illuminated. Crucially it responds to a well-separated wavelength from ChR2, so both can be present in the same animal and used to excite or silence the same circuit during one experiment.
Is optogenetics used in humans?
Only in narrow, specialised cases so far. It requires delivering a gene into target cells and getting light to them, and blue light penetrates only about a millimetre of brain tissue — deep-brain work needs an implanted fibre. The most discussed clinical application is retinal disease, where the target cells are directly accessible to light.
Why did this win a Nobel Prize?
Because it changed what neuroscience could ask. Previously researchers could observe that a region was active during a behaviour, or disrupt it crudely and see what broke. Optogenetics allows a direct causal test — make exactly these cells fire, right now, and see whether the behaviour follows — with control over cell type, location and timing simultaneously.
Sources
- Nagel et al. — Channelrhodopsin-2, a directly light-gated cation-selective membrane channel, PNAS (2003)
- Boyden, Zhang, Bamberg, Nagel & Deisseroth — Millisecond-timescale, genetically targeted optical control of neural activity, Nature Neuroscience (2005)
- Zhang et al. — Multimodal fast optical interrogation of neural circuitry, Nature (2007)
- The Nobel Prize in Physiology or Medicine 2026
